companydata.dkLUNDBECK PHARMA A/S
CVR: 56750215
Lundbeck Pharma A/S demonstrates a positive financial trajectory, with revenue increasing from 15,968,000 DKK in 2023 to 18,887,000 DKK in 2025, reflecting a steady growth trend. Profitability has also improved, rising from 991,000 DKK in 2023 to 2,291,000 DKK in 2025, indicating enhanced operational efficiency and margins. However, equity has slightly declined from 3,484,000 DKK in 2024 to 3,378,000 DKK in 2025, which may raise concerns regarding financial stability. Positioned within the pharmaceutical wholesale industry, Lundbeck Pharma's growth and profitability suggest a solid standing, though ongoing monitoring of equity and market conditions is advisable.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive handelsvirksomhed med human medicin samt, efter bestyrlsens skøn, anden i forbindelse dermed stående virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 18.9 mio. | 2.3 mio. | 19.5 mio. | 3.4 mio. | 18 | |
History
Ownership
Management
Directors
Board
Production units (2)
Similar companies
Companies in the same industry and area